SELLAS Life Sciences (SLS) Asset Utilization Ratio (2013 - 2022)
SELLAS Life Sciences (SLS) reported Asset Utilization Ratio of 0.04 for Q4 2022, down 82.0% year-over-year from 0.24 in Q4 2021, and up 24.0% on a QoQ basis from 0.03 in Q3 2022.
SELLAS Life Sciences (SLS) has 6 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2022.
- Quarterly Asset Utilization Ratio fell 82.0% year-over-year to 0.04 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.04 (down 82.0% YoY) and the FY2022 annual result came in at 0.04, down 79.85% from the prior year.
- Asset Utilization Ratio grew to 0.04 in Q4 2022 per SLS's latest filing, from 0.03 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.55 in Q1 2020 and bottomed at 0.03 in Q3 2022.
- The 3-year median for Asset Utilization Ratio is 0.19 (2020), against an average of 0.19.
- The widest annual swing landed in 2021, when Asset Utilization Ratio surged 302.06%; it then slumped 85.25% in 2022.
- Tracing SLS's Asset Utilization Ratio over 3 years: stood at 0.06 in 2020, then jumped by 302.06% to 0.24 in 2021, then slumped by 82.0% to 0.04 in 2022.
- Per Business Quant, the three latest SLS Asset Utilization Ratio figures stand at 0.04 (Q4 2022), 0.03 (Q3 2022), and 0.04 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.85 |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | 0.23 |
| Jun 30, 2021 | 0.23 |
| Mar 31, 2021 | 0.18 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.20 |
| Jun 30, 2020 | 0.39 |
| Mar 31, 2020 | 0.55 |
| Jun 30, 2015 | 0.10 |
| Mar 31, 2015 | 0.10 |
| Dec 31, 2014 | 0.12 |
| Sep 30, 2014 | 0.12 |
| Jun 30, 2014 | 0.11 |
| Mar 31, 2014 | 0.10 |
| Dec 31, 2013 | 0.10 |
| Sep 30, 2013 | 0.06 |
| Jun 30, 2013 | 0.07 |
| Mar 31, 2013 | 0.04 |